Oncocyte: Joshua Riggs

Oncocyte has appointed Joshua Riggs as CEO effective Feb. 24, 2023. Riggs was named interim CEO in December, after serving as director of business development and general manager of transplant beginning in 2020. He also serves as president and joins the company's board of directors. Prior to joining Oncocyte, Riggs was a business development strategist with experience working with growth-stage molecular diagnostics companies. He has also served as a principal at Bethesda Group.